Home
About Xianju
Into Xianju
Company Culture
Contact Us
Our Products
FDFs
API & INTERMEDIATES
CDMO & CMO
R&D and Innovation
Innovation Dynamics
R&D Pipeline
Innovation Platform
R&D Introduction
Investor Relations
Stock Info
Investor Contact
Social Responsibility
ESG
sustain development
CN
CN
Index
About Xianju
Into Xianju
Company Culture
Contact Us
Our Products
FDFs
API & INTERMEDIATES
CDMO & CMO
R&D and Innovation
Innovation Dynamics
R&D Pipeline
Innovation Platform
R&D Introduction
Investor Relations
Stock Info
Investor Contact
Social Responsibility
ESG
sustain development
Search
Search Results
Product Search(29)
News Search(65)
XIANJU PHARMA obtained the registration certificate for domestic production of Methylprednisolone Tablets
2021.10.30
Ropivacaine Hydrochloride Injection of XIANJU PHARMA passed consistency evaluation
2021.06.02
Finasteride Tablets of XIANJU PHARMA passed consistency evaluation
2021.03.09
Finasteride Tablets of XIANJU PHARMA passed consistency evaluation
2021.01.22
Rocuronium Bromide Injection of XIANJU PHARMA passed consistency evaluation
2020.12.10
首页
1
2
…
9
10
11
末页
跳至
页
GO
More
2021.10.30
2021.06.02
2021.03.09
2021.01.22
2020.12.10
